Back
Genmab AS Vs. Novo Nordisk AS Industry Stock Comparison
Sell
37
GMAB
Genmab AS
Last Price:
27.51
Seasonality Move:
8.67%
Sell
40
NVO
Novo Nordisk AS
Last Price:
131.20
Seasonality Move:
3.35%
Sell
37
Genmab AS (GMAB)
is a Sell
Is Genmab AS a Buy, Sell or Hold?
- The current Genmab AS [GMAB] share price is $27.50. The Score for GMAB is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- GMAB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
- The current Novo Nordisk AS [NVO] share price is $131.14. The Score for NVO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GMAB Stock Price Chart
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $131.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.
GMAB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.14 | Buy |
Relative Strength Index (14 RSI): | 51.6 | Buy |
Chaikin Money Flow: | -292698 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.66 - 27.76) | Buy |
Bollinger Bands (100): | (26.32 - 28.86) | Sell |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.05 | Buy |
Relative Strength Index (14 RSI): | 44.39 | Sell |
Chaikin Money Flow: | -1766560 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (128.81 - 137.53) | Sell |
Bollinger Bands (100): | (127.92 - 140.64) | Sell |
GMAB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.68 | Sell |
20-day SMA: | 27.3 | Buy |
50-day SMA: | 27.01 | Buy |
200-day SMA: | 28.8 | Sell |
8-day EMA: | 27.57 | Sell |
20-day EMA: | 27.44 | Buy |
50-day EMA: | 27.35 | Buy |
200-day EMA: | 29.2 | Sell |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 134.9 | Sell |
20-day SMA: | 134.91 | Sell |
50-day SMA: | 134.97 | Sell |
200-day SMA: | 124.47 | Buy |
8-day EMA: | 134.02 | Sell |
20-day EMA: | 134.26 | Sell |
50-day EMA: | 134.35 | Sell |
200-day EMA: | 123.99 | Buy |
Genmab AS Earnings Growth & GMAB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.11 per share, an increase this year of $0.07 per share, and an increase next year of $0.33 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.70 per share, and an increase next year of $0.92 per share.
Genmab AS Technical Analysis
Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |